Versartis Inc. (Nasdaq: VSAR) widened third quarter losses more than expected. Shares of the biopharmaceutical lost 40 cents to close at $1.90.
Versartis widens losses
October 27, 2017 at 19:11 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|